Health Technology Sector Company Archives - KooCapital.Com

Sanofi India Limited Company Profile | KooCapital.Com

KooCapital.Com — Thu, 20 Oct 2022 08:26:25 +0000

SANOFI INDIA LIMITED Company Profile Details at KooCapital.Com – Stock Market News Portal.

Sanofi India Limited engages in the manufacture and distribution of pharmaceutical drugs. The firm offers its products under the following brands: AllStar, Amaryl M, Amaryl M Forte, Amaryl MV, Apidra, Arava, Augeoz, Brodactam, Cardace, Cardace Protect, Cardace AM, Cardace Meto, Caspercid, Cetapin P, Cetapin XR, Cetapin V, Clexane, Daonil, Daonil M, Frisium, Insuman Rapid, Insuman Comb 25, Insuman Comb 50, Lantus, Lasilactone 50 Lasix, Metosan XR, M-Nem, Amaryl, Renvela Sachets, Semi-Daonil, Targocid, Taxotere, Telsite, Telsite AM, Telsite AM H, Telsite H, Trenta, Vinlep, and Zolineg. It also focuses on the following therapeutic areas: diabetes, cardiology, consumer healthcare, hospital, central nervous system, and anti-histamines. The company was founded on May 2, 1956 and is headquartered in Mumbai, India.

sanofi india limited company operating in Health Technology Sector and dealing in Pharmaceuticals: Major. sanofi india limited is SEBI Listed Company (India) and having:-

ISIN (An International Securities Identification Number): INE058A01010
Equity Stock (National Stock Exchange) Symbol: SANOFI
NSE Link IS: https://www.nseindia.com/get-quotes/equity?symbol=SANOFI
BSE Link IS: https://www.bseindia.com/stock-share-price/sanofi-india-ltd/SANOFI/500674/

Sanofi India is engaged in Business of Manufacture and sale of pharmaceutical products.

India – Branded generics (79% of CY20 revenues):[1] Top-7 brands contribute ~70% of domestic sales and are growing at high single digits.

Sanofi India Ltd stand with []

Company Website: http://www.sanofiindialtd.com/
Company Website2: http://www.sanofiindialtd.com/
LinkedIn page URL: https://in.linkedin.com/company/sanofi-india-ltd
Wiki Profile URL:

#sanofi #india #limited #company #management #company #history #company #profile #company #information #business #directory #stock #market #news #annual #report #quarterly #results #profit #and #loss #koo #capital #koocapital #com #koocapital #news #health #technology #sector #company #pharmaceuticals #major #industry

The post Sanofi India Limited Company Profile | KooCapital.Com appeared first on KooCapital.Com.

Wockhardt Limited – Company Profile – Company information | KooCapital.Com

KooCapital.Com — Fri, 14 Oct 2022 10:38:33 +0000

WOCKHARDT LIMITED Company Profile Details at KooCapital.Com – Stock Market News Portal.

Wockhardt Limited engages in the pharmaceutical business. Its products include formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients. The company was founded by Habil Fakhruddin Khorakiwala in 1967 and is headquartered in Mumbai, India.

wockhardt limited company operating in Health Technology Sector and dealing in Pharmaceuticals: Other. wockhardt limited is SEBI Listed Company (India) and having:-

ISIN (An International Securities Identification Number): INE049B01025
Equity Stock (National Stock Exchange) Symbol: WOCKPHARMA
NSE Link IS: https://www.nseindia.com/get-quotes/equity?symbol=WOCKPHARMA
BSE Link IS: https://www.bseindia.com/stock-share-price/wockhardt-ltd/WOCKPHARMA/532300/

Wockhardt is a Global Pharmaceutical and Biotech Company and is India’s leading research-based global healthcare enterprise with relevance in the fields of Pharmaceuticals, Biotechnology, and a chain of advanced Super Speciality Hospitals.[1]

Wockhardt is a global pharmaceutical and biotechnology organisation, providing affordable, high-quality medicines for a healthier world. It is India’s leading research-based global healthcare enterprise with relevance in the fields of Pharmaceuticals, Biotechnology and a chain of advanced Super Speciality Hospitals.

Wockhardt is a true Indian Multi-National Company with a multi-ethnic workforce of 8600 Wockhardt Associates from 21 different nationalities globally. It has 3 research centres and 12 manufacturing plants, with businesses ranging from the manufacture and marketing of Pharmaceutical and Bio-pharmaceutical formulations, Active Pharmaceutical Ingredients (APIs) and Vaccines.

Headquatered in Mumbai, India, Wockhardt has full-fledged operations in the USA, UK, Ireland and France. It also has its marketing presence in emerging markets of Russia, Brazil, Mexico, Vietnam, Philippines, Nigeria, Kenya, Ghana, Tanzania, Uganda, Nepal, Myanmar, Sri Lanka, Mauritius, Lebanon and Kuwait.

Wockhardt’s core business is innovation. It uses science and technology to develop medicines and other products that improve the quality of millions people’s lives through better health.

Wockhardt aspires to create a healthier world. Its strategic vision of ‘More & More with Less & Less’ has transformed into new ways of thinking, a new journey for growth, medical breakthroughs for patients and continuing value for all stakeholders.

Wockhardt Ltd. stand with []

Company Website: http://www.wockhardt.com/
Company Website2: http://www.wockhardt.com/
LinkedIn page URL: https://in.linkedin.com/company/wockhardt
Wiki Profile URL: https://en.wikipedia.org/wiki/Wockhardt

#wockhardt #limited #company #management #company #history #company #profile #company #information #business #directory #stock #market #news #annual #report #quarterly #results #profit #and #loss #koo #capital #koocapital #com #koocapital #news #health #technology #sector #company #pharmaceuticals #other #industry

The post Wockhardt Limited – Company Profile – Company information | KooCapital.Com appeared first on KooCapital.Com.

Jagsonpal Pharmaceuticals Limited – Company Profile – Company information | KooCapital.Com

KooCapital.Com — Fri, 14 Oct 2022 09:58:11 +0000

JAGSONPAL PHARMACEUTICALS LIMITED Company Profile Details at KooCapital.Com – Stock Market News Portal.

Jagsonpal Pharmaceuticals Limited is a pharmaceutical company, which engages in the development and manufacture of intermediate drugs and pharmaceutical formulations. Its products include capsule, tablet, and ampoule. The company was founded by Jagmohan Singh Kochhar in 1964 and is headquartered in New Delhi, India.

jagsonpal pharmaceuticals limited company operating in Health Technology Sector and dealing in Pharmaceuticals: Other. jagsonpal pharmaceuticals limited is SEBI Listed Company (India) and having:-

ISIN (An International Securities Identification Number): INE048B01027
Equity Stock (National Stock Exchange) Symbol: JAGSNPHARM
NSE Link IS: https://www.nseindia.com/get-quotes/equity?symbol=JAGSNPHARM
BSE Link IS: https://www.bseindia.com/stock-share-price/jagsonpal-pharmaceuticals-ltd/JAGSNPHARM/507789/

Jagsonpal Pharmaceuticals is primarily engaged in the manufacturing and trading of pharmaceutical products and APIs. The Company has operations in India and caters to both domestic and international markets.

Jagsonpal is among India’s premier pharmaceutical companies. Jagsonpal has substantial research and development, manufacturing, marketing, and distribution facilities. An impeccable track record of growth and profitability spanning over 4 decades, makes Jagsonpal an ideal company to partner with. Founded in 1964 the company specializes in developing and manufacturing bulk drugs and pharmaceutical formulations. Over the past 50 years, the firm has grown by leaps and bounds. The firm is committed to sustainable growth and is aggressively pursuing growth through market penetration, market expansion, and multi-national expansion. The firm’s objective is to increase market share and become a dominant player in the Indian Pharmaceutical Industry. Jagsonpal has an expanding international portfolio of affiliates, joint ventures and representative offices across the globe making it a truly international operation. The firm is represented by 2,500 agents worldwide and has offices in 3 continents. The company’s operations span Russia, Brazil, USA, Ukraine, Sri Lanka, Cameroon, Thailand, Argentina, Germany, Switzerland, Korea, Egypt and Vietnam making Jagsonpal’s reach truly global.

Jagsonpal Pharmaceuticals Ltd. stand with [An influential science based patient-centric healthcare provider offering trustworthy products with exceptional quality]

Company Website: http://www.jagsonpal.com/
Company Website2: http://www.jagsonpal.com/
LinkedIn page URL: https://in.linkedin.com/company/jagsonpal-pharmaceuticals
Wiki Profile URL:

#jagsonpal #pharmaceuticals #limited #company #management #company #history #company #profile #company #information #business #directory #stock #market #news #annual #report #quarterly #results #profit #and #loss #koo #capital #koocapital #com #koocapital #news #health #technology #sector #company #pharmaceuticals #other #industry

The post Jagsonpal Pharmaceuticals Limited – Company Profile – Company information | KooCapital.Com appeared first on KooCapital.Com.

Glenmark Life Sciences Limited – Company Profile | KooCapital.Com

KooCapital.Com — Sun, 09 Oct 2022 15:14:25 +0000

GLENMARK LIFE SCIENCES LIMITED Company Profile Details at KooCapital.Com – Stock Market News Portal.

Glenmark Life Sciences Limited engages in the development and manufacture of non-commoditized active pharmaceutical ingredients. Its products focuses on chronic therapeutic areas, including cardiovascular disease, central nervous system disease, pain management, and diabetes. The company was founded on June 23, 2011 and is headquartered in Mumbai, India.

glenmark life sciences limited company operating in Health Technology Sector and dealing in Pharmaceuticals: Major. glenmark life sciences limited is SEBI Listed Company (India) and having:-

ISIN (An International Securities Identification Number): INE03Q201024
Equity Stock (National Stock Exchange) Symbol: GLS
NSE Link IS: https://www.nseindia.com/get-quotes/equity?symbol=GLS
BSE Link IS: https://www.bseindia.com/stock-share-price/glenmark-life-sciences-ltd/GLS/543322/

Glenmark Life Sciences, a subsidiary of Glenmark Pharmaceuticals Ltd, is one of the leading developers and manufacturers of select high-value Active Pharmaceutical Ingredients. The company further operates in Contract Development and manufacturing operations to offer services to specialty Pharmaceutical companies.

A subsidiary of Glenmark Pharmaceuticals[1] Glenmark Life Sciences (GLS) is a subsidiary of Glenmark Pharmaceuticals Ltd which launched the API business by setting up a manufacturing facility in 2001 to cater to the growth in the API segment across the world and in 2019, the API manufacturing business of Glenmark was spun off into GLS, which will act as an independent company and focus on API business

Glenmark Life Sciences (GLS) develops and manufactures a range of high-quality, industry-leading Active Pharmaceutical Ingredients (APIs) for pharmaceutical companies worldwide. Leveraging our state-of-the-art laboratories and manufacturing locations, we supply over 130 molecules to more than 700 customers, which include the world’s top 20 generic companies. From product selection & development to commercialization, we judiciously blend science, technology and economics to stay ahead of the curve. Our culture of environmental stewardship, responsible business practices and operational excellence makes us one of the most reliable and preferred partner in the industry. Our track record of regulatory compliance, cost advantage, speed and superior quality ensures business continuity for our customers spread over 65 countries, being one of the fastest growing API companies in the industry. Our revenue, historically generated from US and Europe, is rapidly expanding to new Emerging Geographies like South East Asia, Russia, Middle East, Japan and Latin America.

Our people are our key differentiator. Our knowledgeable, responsible and inspired team, of over 1400 colleagues from 7 nationalities, constantly challenges themselves to forge out-of-the-box solutions. For GLS employees, business is about relationships, hence we work as partners, who intend to preempt, meet and even exceed customer expectations.

At GLS, we embrace an approach to business that lays equal amount of emphasis on generating value for the economy, environment and the society.

GLS (www.glenmarklifesciences.com) was incorporated as an independent subsidiary of Glenmark Pharmaceuticals on January 1, 2019, to provide a strategic focus to the API business and help it unleash its full potential. Glenmark Pharmaceuticals (www.glenmarkpharma.com) is a 40 year-old integrated, research-driven, global pharmaceutical organization committed to enriching lives.

Glenmark Life Sciences stand with [Passion. Innovation. Partnership]

Company Website: http://www.glenmarklifesciences.com/
Company Website2: http://www.glenmarklifesciences.com/
LinkedIn page URL: https://in.linkedin.com/company/glenmark-life-sciences
Wiki Profile URL:

#glenmark #life #sciences #limited #company #management #company #history #company #profile #company #information #business #directory #stock #market #news #annual #report #quarterly #results #profit #and #loss #koo #capital #koocapital #com #koocapital #news #health #technology #sector #company #pharmaceuticals #major #industry

The post Glenmark Life Sciences Limited – Company Profile | KooCapital.Com appeared first on KooCapital.Com.

Nectar Lifesciences Limited Company Profile – KooCapital.Com | Stock Market News

KooCapital.Com — Sun, 09 Oct 2022 14:47:25 +0000

NECTAR LIFESCIENCES LIMITED Company Profile Details at KooCapital.Com – Stock Market News Portal.

Nectar Lifesciences Limited is a holding company, which engages in the manufacture and distribution of pharmaceutical products. Its products include active pharmaceutical ingredients and intermediates; formulations; diagnostics; empty hard gelatin capsules; and menthol. The company was founded by Sanjiv Goyal on June 27, 1995 and is headquartered in Chandigarh, India.

nectar lifesciences limited company operating in Health Technology Sector and dealing in Pharmaceuticals: Other. nectar lifesciences limited is SEBI Listed Company (India) and having:-

ISIN (An International Securities Identification Number): INE023H01027
Equity Stock (National Stock Exchange) Symbol: NECLIFE
NSE Link IS: https://www.nseindia.com/get-quotes/equity?symbol=NECLIFE
BSE Link IS: https://www.bseindia.com/stock-share-price/nectar-lifescience-ltd/NECLIFE/532649/

Nectar Lifesciences a pharmaceutical company, primarily engages in the development, manufacture, and marketing of various active pharmaceutical ingredients (APIs) and finished dosage forms.

Nectar Lifesciences Ltd (NecLife) is a 300 million US$ integrated pharmaceutical organization, offering comprehensive range of Cephalosporin Active Pharmaceutical Ingredients and Finished Dosage Forms. The development and manufacture of quality intermediates, bulk actives have been critical to our success to become one of the largest manufacturers of cephalosporin range of products and delivering innovative and affordable products to domestic as well as international markets. NecLife has tactically positioned itself in the global pharmaceutical industry. It has developed sustainable production systems to manufacture highest quality pharmaceutical products meeting diverse requirements of its customer base in over 45 countries worldwide from its globally approved facilities. Other services and products manufactured by Nectar are:

CRAMS:NecLife is a preferred contract manufacturer for leading pharmaceutical companies providing a full range of services.

Hard Gelatin Capsules: NecLife manufactures two-piece double lock gelatin capsules in all sizes, with customized colours and printing.

In vitro Diagnostics: Nectar manufactures a range of rapid test kits, biochemistry, haematology and serology products in its ISO 13485 approved facility

Natural Products:

Menthol and mint derivatves: NecLife offers the best quality Menthol and Mint Derivatives consistently and has emerged as a major supplier globally. Winner of export award from government of India. First to file USDMF for natural menthol.

Guar Gum: NecLife manufactures highest viscosity guar gum powder for oil and gas, food and pharmaceutical industry.

Nectar Lifesciences Limited stand with []

Company Website: http://www.neclife.com/
Company Website2: http://www.neclife.com/
LinkedIn page URL: https://in.linkedin.com/company/nectar-life-science
Wiki Profile URL: https://en.wikipedia.org/wiki/Nectar_Lifesciences

#nectar #lifesciences #limited #company #management #company #history #company #profile #company #information #business #directory #stock #market #news #annual #report #quarterly #results #profit #and #loss #koo #capital #koocapital #com #koocapital #news #health #technology #sector #company #pharmaceuticals #other #industry

The post Nectar Lifesciences Limited Company Profile – KooCapital.Com | Stock Market News appeared first on KooCapital.Com.

Cipla Limited Company Profile | KooCapital.Com

KooCapital.Com — Sun, 09 Oct 2022 14:06:25 +0000

CIPLA LIMITED Company Profile Details at KooCapital.Com – Stock Market News Portal.

Cipla Limited engages in the manufacture and distribution of healthcare products and bulk drugs. It operates through the following segments: Pharmaceuticals and New Ventures. The Pharmaceuticals segment develops, manufactures, sells and distributes generic or branded generic medicines as well as active pharmaceutical ingredients. The New Ventures segment includes the operations of the two wholly owned subsidiaries, Cipla Health Ltd., a consumer healthcare company and Cipla BioTec Pvt. Ltd, which is into the business of Biosimilars. The company was founded by Khwaja Abdul Hamied in 1935 and is headquartered in Mumbai, India.

cipla limited company operating in Health Technology Sector and dealing in Pharmaceuticals: Other. cipla limited is SEBI Listed Company (India) and having:-

ISIN (An International Securities Identification Number): INE059A01026
Equity Stock (National Stock Exchange) Symbol: CIPLA
NSE Link IS: https://www.nseindia.com/get-quotes/equity?symbol=CIPLA
BSE Link IS: https://www.bseindia.com/stock-share-price/cipla-ltd/CIPLA/500087/

Cipla is engaged in the Business of Pharmaceuticals.(Source : 202003 Annual Report Page No:157)

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. For over 80 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 100 countries. Our portfolio includes over 1000 products across wide range of therapeutic categories with one quality standard globally.

Whilst delivering a long-term sustainable business, Cipla recognises its duty to provide affordable medicines. Cipla’s emphasis on access for patients was recognised globally for the pioneering role played in HIV/AIDS treatment as the first pharmaceutical company to provide a triple combination anti-retroviral (ARV) in Africa at less than a dollar a day and thereby treating many millions of patients since 2001.

Cipla’s research and development focuses on developing innovative products and drug delivery systems.

Cipla stand with []

Company Website: http://www.cipla.com/
Company Website2: http://www.cipla.com/
LinkedIn page URL: https://in.linkedin.com/company/cipla
Wiki Profile URL: https://en.wikipedia.org/wiki/Cipla

#cipla #limited #company #management #company #history #company #profile #company #information #business #directory #stock #market #news #annual #report #quarterly #results #profit #and #loss #koo #capital #koocapital #com #koocapital #news #health #technology #sector #company #pharmaceuticals #other #industry

The post Cipla Limited Company Profile | KooCapital.Com appeared first on KooCapital.Com.

Syngene International Limited – Company Profile – Company information | KooCapital.Com

KooCapital.Com — Sun, 09 Oct 2022 14:05:26 +0000

SYNGENE INTERNATIONAL LIMITED Company Profile Details at KooCapital.Com – Stock Market News Portal.

Syngene International Limited operates as a global discovery, development and manufacturing organization providing integrated scientific services to the pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical industries. It is engaged providing contract research and manufacturing services. The firm’s services include discovery chemistry, discovery biology, safety assessment, large molecule development, chemical development, formulation development, stability studies, polymer research, integrated discovery and development, and clinical development. The company was founded on November 18, 1993 and is headquartered in Bangalore, India.

syngene international limited company operating in Health Technology Sector and dealing in Biotechnology. syngene international limited is SEBI Listed Company (India) and having:-

ISIN (An International Securities Identification Number): INE398R01022
Equity Stock (National Stock Exchange) Symbol: SYNGENE
NSE Link IS: https://www.nseindia.com/get-quotes/equity?symbol=SYNGENE
BSE Link IS: https://www.bseindia.com/stock-share-price/syngene-international-ltd/SYNGENE/539268/

Syngene (established in 1993) as a Biocon subsidiary is India’s first Contract Research Organization (CRO) which expanded later to be an integrated service provider offering end-to-end drug discovery, development, and manufacturing services on a single platform (CRAMS). Total research & manufacturing infrastructure for the company is spread across 1.9 million square feet across locations.

Business Footprint: The company caters to diverse end-user industries like Pharmaceuticals, Animal Health, Agrochemicals, Consumer Packaged Goods, Chemicals/Polymers. It has 360+ active customers with engagements with 8 out of the top 10 global pharma companies. The company holds 400+ patents jointly with clients and has a base of 4200+ scientists.

Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022) is an integrated contract research, development and manufacturing organization providing scientific services – from early discovery to commercial supply. Our innovative capabilities for novel molecular entities (NMEs) cater to a wide range of industrial sectors, including pharmaceutical, biotechnology, nutrition, animal health, consumer goods and speciality chemical companies.

Our Discovery services include conducting early-stage research from target identification to delivery of drug candidates for further development. Development services encompass activities from pre-clinical to clinical trials including Drug Substance Development (DSP), Drug Product Development (DPD) and associated services to demonstrate safety, tolerability and efficacy of the selected drug candidate.

Our Manufacturing services for small and large molecules include cGMP-compliant facilities for clinical supplies, registration batches as well as commercial volumes through our API manufacturing plant & disposable Biologics manufacturing facility.

Driving our innovative culture is our highly qualified team of 4700+ scientists supported by state-of-the-art infrastructure and market-leading technology. Our scientists have both the skills and the capability to deliver great science, ensure robust data management, IP security & quality manufacturing, at speed, to improve time-to-market and lower the cost of innovation.

With 2 Mn sq ft of specialist discovery, development & manufacturing facilities, Syngene offers dedicated research facilities for Amgen, Baxter, Bristol-Myers Squibb and Herbalife. We also work with biotech companies pursuing leading-edge science as well as multinationals including GSK and Merck KGaA. Smaller and virtual companies, non-profit institutions, academic centers and start-ups also collaborate with us for their research-related requirements.

Write to us at bdc@syngeneintl.com

Syngene International Limited stand with [An innovation-led, contract research, development & manufacturing organization offering integrated scientific services]

Company Website: https://www.syngeneintl.com/
Company Website2: http://www.syngeneintl.com/
LinkedIn page URL: https://in.linkedin.com/company/syngene-international-limited
Wiki Profile URL:

#syngene #international #limited #company #management #company #history #company #profile #company #information #business #directory #stock #market #news #annual #report #quarterly #results #profit #and #loss #koo #capital #koocapital #com #koocapital #news #health #technology #sector #company #biotechnology #industry

The post Syngene International Limited – Company Profile – Company information | KooCapital.Com appeared first on KooCapital.Com.

Sun Pharmaceutical Industries Limited – Company Profile – Company information | KooCapital.Com

KooCapital.Com — Sun, 09 Oct 2022 10:58:06 +0000

SUN PHARMACEUTICAL INDUSTRIES LIMITED Company Profile Details at KooCapital.Com – Stock Market News Portal.

Sun Pharmaceutical Industries Limited engages in manufacturing, developing, and marketing of pharmaceuticals products. It offers tablets, capsules, injectable, inhalers, ointments, creams, and liquids. The company was founded by Dilip Shantilal Shanghvi in 1983 and is headquartered in Mumbai, India.

sun pharmaceutical industries limited company operating in Health Technology Sector and dealing in Pharmaceuticals: Major. sun pharmaceutical industries limited is SEBI Listed Company (India) and having:-

ISIN (An International Securities Identification Number): INE044A01036
Equity Stock (National Stock Exchange) Symbol: SUNPHARMA
NSE Link IS: https://www.nseindia.com/get-quotes/equity?symbol=SUNPHARMA
BSE Link IS: https://www.bseindia.com/stock-share-price/sun-pharmaceuticals-industries-ltd/SUNPHARMA/524715/

Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharma Ingredients (APIs). The company and its subsidiaries has various manufacturing facilities spread across the world with trading and other incidental and related activities extending to global market.

Product Offerings The company produces a comprehensive and diverse portfolio of generic and specialty medicines targeting wide spectrum of chronic and acute treatments. Its product portfolio includes generics, branded generics, specialty, difficult-to-make technology intensive products, anti-retrovirals, APIs and intermediates. It offers medicines in all form of dosages i.e. injectables, sprays, ointments, creams, liquids, tablets and capsules.

Sun Pharma is the world’s fourth largest specialty generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma’s global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe and a multi-cultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising around 2,000 scientists and R&D investments of over 7-8% of annual revenues.

See our community guideline: bit.ly/2WYiDZ5

SUN PHARMA stand with [Reaching People. Touching Lives.]

Company Website: http://www.sunpharma.com/
Company Website2: http://www.sunpharma.com/
LinkedIn page URL: https://in.linkedin.com/company/sun-pharma
Wiki Profile URL: https://en.wikipedia.org/wiki/Sun_Pharma

#sun #pharmaceutical #industries #limited #company #management #company #history #company #profile #company #information #business #directory #stock #market #news #annual #report #quarterly #results #profit #and #loss #koo #capital #koocapital #com #koocapital #news #health #technology #sector #company #pharmaceuticals #major #industry

The post Sun Pharmaceutical Industries Limited – Company Profile – Company information | KooCapital.Com appeared first on KooCapital.Com.

Dr. Reddy’s Laboratories Limited Company Profile – KooCapital.Com | Stock Market News

KooCapital.Com — Sun, 09 Oct 2022 10:40:05 +0000

DR. REDDY’S LABORATORIES LIMITED Company Profile Details at KooCapital.Com – Stock Market News Portal.

Dr. Reddy’s Laboratories Limited engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services & Active Ingredients, Proprietary Products, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services & Active Ingredients segment is comprised of manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Proprietary Products segment focuses on research and development of differentiated formulations. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

dr. reddy’s laboratories limited company operating in Health Technology Sector and dealing in Pharmaceuticals: Generic. dr. reddy’s laboratories limited is SEBI Listed Company (India) and having:-

ISIN (An International Securities Identification Number): INE089A01023
Equity Stock (National Stock Exchange) Symbol: DRREDDY
NSE Link IS: https://www.nseindia.com/get-quotes/equity?symbol=DRREDDY
BSE Link IS: https://www.bseindia.com/stock-share-price/dr-reddys-laboratories-ltd/DRREDDY/500124/

Dr. Reddy’s Laboratories Ltd is a leading India-based pharamceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations.

Global Generics Segment (~80% of revenues) This is the main business of the company wherein it offers 400+ high-quality generic drugs, keeping costs reasonable by leveraging its integrated operations. The company benefits from its expertise in active ingredients, product development skills, a keen understanding of regulations and intellectual property rights & streamlined supply chain.

Dr. Reddy’s Laboratories Ltd. is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses – Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations. Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Dr. Reddy’s operates in markets across the globe. Our major markets include – USA, India, Russia & CIS countries, and Europe. For more information, log on to: www.drreddys.com For more information, log on to: www.drreddys.com

Dr. Reddy’s Laboratories stand with [We accelerate access to affordable and innovative medicines because Good Health Can’t Wait.]

Company Website: http://www.drreddys.com/
Company Website2: http://www.drreddys.com/
LinkedIn page URL: https://in.linkedin.com/company/dr–reddys-laboratories
Wiki Profile URL: https://en.wikipedia.org/wiki/Dr._Reddy’s_Laboratories

#dr #reddy’s #laboratories #limited #company #management #company #history #company #profile #company #information #business #directory #stock #market #news #annual #report #quarterly #results #profit #and #loss #koo #capital #koocapital #com #koocapital #news #health #technology #sector #company #pharmaceuticals #generic #industry

The post Dr. Reddy’s Laboratories Limited Company Profile – KooCapital.Com | Stock Market News appeared first on KooCapital.Com.

Alembic Pharmaceuticals Limited – Company Profile – Company information | KooCapital.Com

KooCapital.Com — Sun, 09 Oct 2022 08:16:06 +0000

ALEMBIC PHARMACEUTICALS LIMITED Company Profile Details at KooCapital.Com – Stock Market News Portal.

Alembic Pharmaceuticals Limited is a research and development pharmaceutical company. It is engaged in the research, development, manufacture, and market of generic and branded pharmaceutical products. The firm’s businesses are Active Pharmaceutical Ingredients and Formulations. It focuses on the following therapeutic areas: Dermatology, Cardiology, Anti-Diabetic, Gastrology, Ophthalmology, Nephrology and Urology, Anti-Infective, Oncology, and cold and cough. The company was founded in 1907 and is headquartered in Vadodara, India.

alembic pharmaceuticals limited company operating in Health Technology Sector and dealing in Pharmaceuticals: Other. alembic pharmaceuticals limited is SEBI Listed Company (India) and having:-

ISIN (An International Securities Identification Number): INE901L01018
Equity Stock (National Stock Exchange) Symbol: APLLTD
NSE Link IS: https://www.nseindia.com/get-quotes/equity?symbol=APLLTD
BSE Link IS: https://www.bseindia.com/stock-share-price/alembic-pharmaceuticals-ltd/APLLTD/533573/

Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients. The company has 3 R&D and 5 manufacturing facilities.

52% turnover from International Generics [1] Alembic Pharma operates through 3 primary business segments – International generics (52% of sales, with 75% being from the US), Domestic branded business (32% of sales), and API business(16% of sales) as of Q3FY21.

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India. Alembic’s manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh. The plant at Vadodara has the largest fermentation capacity in India. The Panelav facility houses the API and formulation manufacturing (both US FDA approved) plants. The plant at Baddi, Himachal Pradesh manufactures formulations for the domestic and non-regulated export market. The company has a state of the art Research Centre at Vadodara.

Alembic Pharmaceuticals Limited stand with []

Company Website: http://www.alembic-india.com/
Company Website2: http://www.alembic-india.com/
LinkedIn page URL: https://in.linkedin.com/company/alembic
Wiki Profile URL:

#alembic #pharmaceuticals #limited #company #management #company #history #company #profile #company #information #business #directory #stock #market #news #annual #report #quarterly #results #profit #and #loss #koo #capital #koocapital #com #koocapital #news #health #technology #sector #company #pharmaceuticals #other #industry

The post Alembic Pharmaceuticals Limited – Company Profile – Company information | KooCapital.Com appeared first on KooCapital.Com.